Aion Therapeutic Inc. reported earnings results for the first quarter ended July 31, 2023. For the first quarter, the company reported net loss was CAD 0.32858 million compared to net income of CAD 0.293317 million a year ago. Basic loss per share from continuing operations was CAD 0.002 compared to basic earnings per share from continuing operations of CAD 0.002 a year ago.

Diluted loss per share from continuing operations was CAD 0.002 compared to diluted earnings per share from continuing operations of CAD 0.002 a year ago.